Rechallenge
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| PD-L1 Inhibitor Rechallenge After Immunotherapy-Related Pneumonitis in Patients With Lung Cancer (NCT07775820) | Nanfang Hospital, Southern Medical University | 2025-10-20 |
Track Rechallenge automatically
Every clearance here is in the API, with alerts when new ones post.